Vaxonyx
Vaxonyx provides solutions that accelerate biotech discovery and development through AI-powered analysis and molecular biology. The company uses AI-driven analytics to optimize DNA design, improve vaccine and immunotherapy platforms, and advance delivery methods, targeting biopharma and research organizations. It combines core technologies in AI, synthetic biology, and preclinical services (IND-enabling studies, assay development, stable cell line generation, and protein/antigen production under BSL-2) with partnerships and consulting. The business operates in the B2B space as a contract research and development partner for next-generation therapeutics. Vaxonyx aims to scale access to advanced therapeutics for global health challenges by integrating data science with wet-lab capabilities.
Vaxonyx
Vaxonyx provides solutions that accelerate biotech discovery and development through AI-powered analysis and molecular biology. The company uses AI-driven analytics to optimize DNA design, improve vaccine and immunotherapy platforms, and advance delivery methods, targeting biopharma and research organizations. It combines core technologies in AI, synthetic biology, and preclinical services (IND-enabling studies, assay development, stable cell line generation, and protein/antigen production under BSL-2) with partnerships and consulting. The business operates in the B2B space as a contract research and development partner for next-generation therapeutics. Vaxonyx aims to scale access to advanced therapeutics for global health challenges by integrating data science with wet-lab capabilities.